Paul Goldsmith MA, BM, BCh, MRCP, PhD

Dr. Paul Goldsmith was awarded a triple 1st from Cambridge and a clinical scholarship from Oxford. Following general medical training, he sub-specialized in neurology, before completing a Ph.D. in a developmental biology lab, taking a systems biology approach to understanding human disease. He was the principal founder of DanioLabs Ltd in 2002, which utilized disease modeling for systematic drug repurposing, established discovery programs in several areas, and generated a product pipeline, the most advanced of which now has positive Phase 2 data.

He was then part of the team that reinvigorated Psychology Online Ltd, a digital health company, with a new business plan, management team, and financing. He co-founded Rubrum Ltd in 2012 to provide semi-automated healthcare provision in insomnia, pain, and COPD to the NHS and other markets through a proprietary online platform and was NED there until 2014. He was also co-founder of Vastrata Ltd, which focused on reprofiling and repurposing, with a virtual business model.

He also has extensive NHS operational and strategic experience, including being NHS England Northern Strategic Clinical Networks (SCN) neuro lead (to May 16), and sitting on an NHS England Urgent and Emergency Care Vanguard and the north Clinical Senate.

Paul is also a Non-Executive Director of the UK Medicines & Healthcare products Regulatory Agency (MHRA).

He has in excess of 50 peer-reviewed publications and patent applications.